The Nigerian pharmaceutical market valued over $2 billion continues to expand due to demand for locally produced medicines. Gaps exist in quality control infrastructure, access to laboratory technologies, and regulatory expectations constrain sector ability to scale and compete.
Against this back
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Chisom Michael
Chisom Michael is a data analyst (audience engagement) and writer at BusinessDay, with diverse experience in the media industry. He holds a BSc in Industrial Physics from Imo State University and an MEng in Computer Science and Technology from Liaoning Univerisity of Technology China. He specialises in listicle writing, profiles and leveraging his skills in audience engagement analysis and data-driven insights to create compelling content that resonates with readers.
